Toggle navigation
CERSI
Excipients
Home
Molecular
Oral
Unresolved
Rarely Used
Products
APIs
Infliximab
Active Ingredient
External Links
Google
,
Wikipedia
,
PubMed
,
DailyMed
,
Raw OpenFDA
,
ECHA
,
ToxNet
,
JECFA
,
FAO
,
21 CFR
All Co-Formulated Excipients (0 Total)
None
Available Products (4 Total)
Product name
Manufacturer
Route
Approved Date
1.
Avsola
Amgen Inc
Intravenous
2.
Inflectra
Pfizer Laboratories Div Pfizer Inc
Intravenous
3.
Remicade
Janssen Biotech, Inc.
Intravenous
4.
Renflexis
Merck Sharp & Dohme Corp.
Intravenous
Comments
Please enable JavaScript to view the
comments powered by Disqus.